Eric Bauge
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr-deficient mice.
Journal: Science translational medicine
Published: May 28, 2025
The evolution of lipid-lowering drugs in the management of cardiovascular disease risk: From the first cardiovascular disease risk-reducing therapies to the novel challenging strategies.
Journal: Pharmacological reviews
Published: December 12, 2024
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Journal: Journal of hepatology
Published: October 03, 2022
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.
Journal: Hepatology (Baltimore, Md.)
Published: December 02, 2021
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis.
Journal: Nature communications
Published: December 01, 2021
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.
Journal: Nature metabolism
Published: November 15, 2021
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver.
Journal: Molecular systems biology
Published: August 05, 2019
Sex-regulated gene dosage effect of PPARα on synaptic plasticity.
Journal: Life science alliance
Published: November 30, 2018
Hepatic PPARα is critical in the metabolic adaptation to sepsis.
Journal: Journal of hepatology
Published: February 13, 2018
Last Updated: 09/26/2026